Viferon® Efficacy in Influenza in Adult Patients

Abstract

The therapeutic efficacy of Viferon® (suppositories of human recombinant interferon alfa-2) was investigated in a double-blind controlled study with the use of Arbidol® as a reference drug in the treatment of patients with influenza. Viferon® and Arbidol® lowered the signs of the fever, intoxication, catarrh and the disease as the whole.

Keywords

• influenza
• therapy
• viferon
• arbidol
• efficacy